Akos CEO and co-founder Kishlay Anand said: “In a time when digital health is rapidly evolving, we are excited to bring this unique approach to virtual medical care.
“At Akos, we’re committed to improving access to high-quality medical care, and this partnership will expand our telehealth offering beyond the capabilities of our telemedicine app.”
Sitting in front of a computer screen and rack of simple, FDA-approved devices, patients are guided by AR through self-administered steps to collect data such as weight, temperature, blood pressure, as well as ear, nose and throat images, and chest, lung and abdomen sounds.
The AI asks questions until details for diagnostic impression is collected. The process takes less than 15 minutes. A complete patient work-up is sent electronically to an Akos provider with a breakdown of predicted illnesses and treatment options.
Through a video consultation, the provider engages with the patient to confirm the AI-collected information, verify the diagnosis, and confirm or modify the treatment plan formulated by the system.
Every detail of the encounter is charted and scribed into the EHR, saving valuable time and improving the engagement between the provider and patient.
The AI also electronically sends the prescription and test orders to the appropriate healthcare partner, e.g. imaging centers, pharmacies, etc., and completes the billing process—which speeds up recovery for the patient and cuts waste out of the system.
Finally, the AI follows up with the patient, at the appropriate time depending on their diagnosis, to check on their health status and determine if a follow-up appointment is warranted.
AdviNOW Medical CEO and founder James Bates said: “We believe our technology will help solve the persistent problem of access to care, by making the visit more efficient, allowing more patients to be seen in a day.
“Our tool will help with the accuracy of data collection, and the importance of follow-up, both of which impact profits, liability, and value-based health outcomes.”
Source: Company Press Release
